Literature DB >> 16522741

Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.

M-J Kim1, J-H Kang, Y G Park, G R Ryu, S H Ko, I-K Jeong, K-H Koh, D-J Rhie, S H Yoon, S J Hahn, M-S Kim, Y-H Jo.   

Abstract

Glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (EX) have been considered as a growth factor implicated in pancreatic islet mass increase and beta-cell proliferation. This study aimed to investigate the effect of EX on cyclin D1 expression, a key regulator of the cell cycle, in the pancreatic beta-cell line INS-1. We demonstrated that EX significantly increased cyclin D1 mRNA and subsequently its protein levels. Although EX induced phosphorylation of Raf-1 and extracellular-signal-regulated kinase (ERK), both PD98059 and exogenous ERK1 had no effect on the cyclin D1 induction by EX. Instead, the cAMP-elevating agent forskolin induced cyclin D1 expression remarkably and this response was inhibited by pretreatment with H-89, a protein kinase A (PKA) inhibitor. Promoter analyses revealed that the cAMP-responsive element (CRE) site (at position -48; 5'-TAACGTCA-3') of cyclin D1 gene was required for both basal and EX-induced activation of the cyclin D1 promoter, which was confirmed by site-directed mutagenesis study. For EX to activate the cyclin D1 promoter effectively, CRE-binding protein (CREB) should be phosphorylated and bound to the putative CRE site, according to the results of electrophoretic mobility shift and chromatin immunoprecipitation assays. Lastly, a transfection assay employing constitutively active or dominant-negative CREB expression plasmids clearly demonstrated that CREB was largely involved in both basal and EX-induced cyclin D1 promoter activities. Taken together, EX-induced cyclin D1 expression is largely dependent on the cAMP/PKA signaling pathway, and EX increases the level of phosphorylated CREB and more potently trans-activates cyclin D1 gene through binding of the CREB to the putative CRE site, implicating a potential mechanism underlying beta-cell proliferation by EX.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522741     DOI: 10.1677/joe.1.06480

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  19 in total

1.  Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.

Authors:  Zhuo Fu; Wen Zhang; Wei Zhen; Hazel Lum; Jerry Nadler; Josep Bassaganya-Riera; Zhenquan Jia; Yanwen Wang; Hara Misra; Dongmin Liu
Journal:  Endocrinology       Date:  2010-05-19       Impact factor: 4.736

Review 2.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

3.  CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner.

Authors:  Mark O Huising; Talitha van der Meulen; Joan M Vaughan; Masahito Matsumoto; Cynthia J Donaldson; Hannah Park; Nils Billestrup; Wylie W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2.

Authors:  Da-Wei Lin; Il-Chi Chang; Alan Tseng; Meng-Ling Wu; Chung-Huang Chen; Cassandra A Patenaude; Matthew D Layne; Shaw-Fang Yet
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

5.  Cyclin D2 protein stability is regulated in pancreatic beta-cells.

Authors:  Lu Mei He; Daniel J Sartori; Monica Teta; Lynn M Opare-Addo; Matthew M Rankin; Simon Y Long; J Alan Diehl; Jake A Kushner
Journal:  Mol Endocrinol       Date:  2009-07-23

6.  The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling.

Authors:  J E Bowe; A Chander; B Liu; S J Persaud; P M Jones
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

7.  Repurposing cAMP-modulating medications to promote β-cell replication.

Authors:  Zhenshan Zhao; Yen S Low; Neali A Armstrong; Jennifer Hyoje Ryu; Sara A Sun; Anthony C Arvanites; Jennifer Hollister-Lock; Nigam H Shah; Gordon C Weir; Justin P Annes
Journal:  Mol Endocrinol       Date:  2014-08-01

8.  Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.

Authors:  Zhengyu Liu; Joel F Habener
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

9.  Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.

Authors:  Rodger E Tiedemann; Xinliang Mao; Chang-Xin Shi; Yuan Xiao Zhu; Stephen E Palmer; Michael Sebag; Ron Marler; Marta Chesi; Rafael Fonseca; P Leif Bergsagel; Aaron D Schimmer; A Keith Stewart
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Rb and p107 are required for alpha cell survival, beta cell cycle control and glucagon-like peptide-1 action.

Authors:  Erica P Cai; Cynthia T Luk; Xiaohong Wu; Stephanie A Schroer; Sally Yu Shi; Tharini Sivasubramaniyam; Jara J Brunt; Eldad Zacksenhaus; Minna Woo
Journal:  Diabetologia       Date:  2014-09-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.